Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy-Reference-Cited by-同舟云学术

Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy

Published:2013-01-09 Issue:7 Volume:33 Page:1791-1795
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Tani Kanae,Takayanagi Risa,Yokoyama Haruko,Yamada Yasuhiko

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-012-2650-7.pdf

Reference13 articles.

1. REMICADE for I.V. infusion (2010) Product Information

2. ACTEMRA for I.V. Infusion (2010) Product Information

3. ENBREL for S.C. injection (2010) Product Information

4. HUMIRA for S.C. injection (2010) Product Information

5. Sugiura M, Sawada Y, Yamada Y, Nakamura K, Iga T (1992) Prediction of therapeutic doses of sulfonylureas based on receptor occupancy theory Xenobio. Metabo Disp 7:233–241

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target occupancy biomarker assay development using a conformation-selective antibody against small-molecule-bound TNF;Bioanalysis;2023-03

2. Utility of in silico prediction of target suppression for antibodies against soluble targets: static versus dynamic models;European Journal of Clinical Pharmacology;2022-11-22

3. An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis;Frontiers in Pharmacology;2022-11-16

4. Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis;Clinical Pharmacokinetics;2015-06-28